Biotechnology Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer’s, Shifts Focus On Newer Medicines – Biogen (NASDAQ:BIIB) Read more
Investing Australian Dollar pares intraday gains as US Dollar improves, focus on Aussie CPI Read more
Stockmarkets Wall Street subdued after mixed earnings, focus on Fed Reuters via biedexmarkets.com Read more
Fintech ECB steps up climate work with focus on green transition, climate and nature-related risks Read more
Investing Australian Dollar moves sideways amid a stable US Dollar, focus on US PCE Price Index Read more